Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 SEK | +6.25% |
|
+3.66% | +10.75% |
04-10 | Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
02-22 | Newbury Pharmaceuticals Secures SEK9 Million Sales Order | MT |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lars Minor
CEO | Chief Executive Officer | 53 | 20-12-31 |
Christoffer Tell
DFI | Director of Finance/CFO | 37 | 20-12-31 |
Director/Board Member | - | 22-07-31 | |
Sales & Marketing | 51 | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 50 | 19-12-31 | |
Director/Board Member | 50 | 19-12-31 | |
Johan Strömqvist
BRD | Director/Board Member | 48 | 19-12-31 |
Anil Okay
BRD | Director/Board Member | 38 | 20-12-31 |
Director/Board Member | - | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,521,154 | 9,005,041 ( 46.13 %) | 0 | 46.13 % |
Company contact information
Newbury Pharmaceuticals AB
Medicon Village Scheeletorget 1
223 81, Lund
+46 46 12 11 20
http://www.newburypharma.com![address Newbury Pharmaceuticals AB(NEWBRY)](https://cdn.zonebourse.com/static/address/131983565.png)
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.75% | 7.42M | |
-10.31% | 8.31B | |
+39.92% | 1.33B | |
-9.54% | 343M | |
+6.08% | 271M | |
+9.44% | 223M | |
-44.71% | 84.89M | |
-29.36% | 67.77M | |
+26.51% | 62.08M |
- Stock Market
- Equities
- NEWBRY Stock
- Company Newbury Pharmaceuticals AB